Company profile

Company profileOfficial Gazette noticesNo confirmed enforcement recordOfficial

CEOLIA Pharma Co., Ltd.

セオリアファーマ株式会社· Corporate Number: 3010001138892

This page aggregates company identity, Official Gazette notices, enforcement records, related-company signals, and source-review links into one public-record profile.

Current page: Company profile

This page brings together Official Gazette notices, enforcement records, registry data, related-company signals, and source-review links for one company. Open individual enforcement records from the history section below.

Free report

Save a public-record evidence report for CEOLIA Pharma Co., Ltd.

Includes company identity, enforcement history, Official Gazette notices, source-review fields, and reviewer notes for internal due-diligence files.

Related tool Kiroku

Monitor website changes for CEOLIA Pharma Co., Ltd.

Open Kiroku monitoring and enter the official website, terms, IR, pricing, or announcement URL you want to track.

Open website monitoring
For developers: JSON integration details

You do not need this for normal browsing. Use it when integrating this company record into an internal tool or AI workflow.

/api/v1/search?q=3010001138892&limit=5

Public Record Summary

Total enforcement
0records
Official Gazette
2notices
Actions in last 3 years
0records
Actions in last year
0records
Latest public record
28 Jul 2025
Total penalties
-
Registry changes
0items

Company Identity and Registry Data

English display name
CEOLIA Pharma Co., Ltd.
Original Japanese name
セオリアファーマ株式会社
Kana name
せおりあふぁーま
Corporate Number
3010001138892
Registered address
東京都中央区日本橋室町3丁目3番1号

Note: Detailed gBizINFO registry data may not be available for this company yet. Use the public registry links below to review supplemental source information.

gBizINFO: fetched 26 Jul 2026

Corporate Number site: fetched 26 Jul 2026

Data sources

Official Gazette

Japanese Official Gazette company notices

2 notice(s)

Official Gazette company notice

Official Gazette noticeCompany noticeTranslation pending
Publication / issue / page
28 Jul 2025 Extra Edition 第171号 p.163
English summary
Company notice
Published company name
セオリアファーマ株式会社
Published address
28日月曜日 官 報 (号 外) 公 告 会社その他の公告 第15期決算公告 令和7年6月 23 日東京都中央区日本橋室町3丁目3番1号
Source
Official Gazette
Show original Japanese extracted fields
Original notice type
決算公告
Original related text
第15期決算公告 / 貸借対照表の要旨 (令和7年3月31日現在)
Original excerpt
第15期決算公告 / 貸借対照表の要旨 (令和7年3月31日現在)
Show official Japanese notice text

号外第 171 号 令和7年7月28日月曜日 官 報 (号  外) 公  告 会社その他の公告page="0163"page="0163"  第15期決算公告  令和7年6月 23 日東京都中央区日本橋室町3丁目3番1号セオリアファーマ株式会社代表取締役 杉本 徹也page="0163"貸借対照表の要旨    (令和7年3月31日現在)科    目金 額(百万円)資産の部流動資産2,057固定資産41  合計  2,098 負債及び 純資産の部 流動負債2,468固定負債34株主資本△404資本金30利益剰余金△434その他利益剰余金△434(うち当期純損失)(577)  合計  2,098©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.

Seoria Pharma Corporation Financial Statements Notice for the 14th Fiscal Period

Financial statements noticeFinancial report
Publication / issue / page
12 Jul 2024 Extra Edition 第167号 p.108
English summary
This is a financial statements notice for the 14th fiscal period, published on July 12, 2024, by Seoria Pharma Corporation. The balance sheet as of March 31, 2024, shows total assets of 1,869,965 thousand yen, with current assets of 1,824,821 thousand yen and fixed assets of 45,144 thousand yen. Liabilities include current liabilities of 1,650,425 thousand yen (including accrued bonuses of 30,932 thousand yen) and fixed liabilities of 47,241 thousand yen. Shareholders' equity totals 172,299 thousand yen, comprising capital stock of 30,000 thousand yen and retained earnings of 142,299 thousand yen, including net income of 4,875 thousand yen for the period.
Published company name
セオリアファーマ株式会社
Published address
12日金曜日 官 報 (号 外) 公 告 会社その他の公告 第14期決算公告 令和6年6月 25 日東京都中央区日本橋室町3丁目3番1号
Translated excerpt
14th fiscal period financial statements / Summary of balance sheet (as of March 31, 2024)
Source
Official Gazette
Show original Japanese extracted fields
Original notice type
決算公告
Original related text
第14期決算公告 / 貸借対照表の要旨 (令和6年3月31日現在)
Original excerpt
第14期決算公告 / 貸借対照表の要旨 (令和6年3月31日現在)
Show official Japanese notice text

号外第 167 号 令和6年7月12日金曜日 官 報 (号  外) 公  告 会社その他の公告page="0108"page="0108"  第14期決算公告  令和6年6月 25 日東京都中央区日本橋室町3丁目3番1号セオリアファーマ株式会社代表取締役 杉本 徹也page="0108"貸借対照表の要旨    (令和6年3月31日現在)科    目金 額(千円)資産の部流動資産1,824,821固定資産45,144  合計  1,869,965 負債及び   純資産の部 流動負債1,650,425(賞与引当金)(30,932)固定負債47,241株主資本172,299資本金30,000利益剰余金142,299その他利益剰余金142,299(うち当期純利益)(4,875)  合計  1,869,965©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.

Enforcement and administrative action history

No enforcement records are currently listed in RegBase's monitored sources.

RegBase automatically collects public disclosures from Japanese government sources. Non-public administrative guidance, oral warnings, and unpublished actions are not included. See data sources.

About this English name

Registered English name from gBizINFO (Japanese Government corporate registry).

If this profile contains an error or your company needs to add context, please use the correction request form. Submissions are reviewed under RegBase editorial policy.

This page mechanically aggregates and structures public government disclosures and public registry data under the editorial policy. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.

CEOLIA Pharma Co., Ltd. Japanese Official Gazette Notices and Company Profile | RegBase